
doi: 10.1007/bf01849305
pmid: 3022567
The Today vaginal contraceptive sponge is made of polyurethane and contains 1 gram of the spermicide nonoxynol-9. Following preclinical and phase I and II clinical trials, extensive worldwide phase III trials were conducted. These multiclinic trials were conducted according to a common protocol with regularly scheduled follow-up visits and examinations. The cumulative first year method effectiveness rate (life table) was 90 per 100 women. The second year rate was 97 per 100 women. No statistically significant difference was found in method failures between nulliparous and parous women. No serious complications occurred in over 1000 women-years of sponge use.
Adult, Clinical Trials as Topic, Nonoxynol, Polyurethanes, Contraceptive Devices, Female, Spermatocidal Agents, Polyethylene Glycols, Pregnancy, Vagina, Humans, Female
Adult, Clinical Trials as Topic, Nonoxynol, Polyurethanes, Contraceptive Devices, Female, Spermatocidal Agents, Polyethylene Glycols, Pregnancy, Vagina, Humans, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
